Literature DB >> 10364646

Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type.

M Golebiowski1, M Barcikowska, A Pfeffer.   

Abstract

A volumetric magnetic resonance imaging assessment of the hippocampal region was done in 50 patients with Alzheimer-type dementia and 25 members of a control group. There were no significant volumetric differences between the right and left hippocampi. The volumetric hippocampal measurements were 39.4% smaller in dementia of the Alzheimer type than in controls. In the differentiation between the analyzed groups of patients, the method had a sensitivity of 95% and a specificity of 92%. A correlation of the hippocampal volumes with the severity of the dementia and the patient's age was found. The results confirmed the importance of hippocampal atrophy in the etiology of dementia. In vivo the quantitative assessment of the hippocampal formation is a valuable tool in the diagnosis of Alzheimer's disease.

Entities:  

Mesh:

Year:  1999        PMID: 10364646     DOI: 10.1159/000017133

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  16 in total

1.  Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment.

Authors:  Klaus H Fritzsche; Bram Stieltjes; Sarah Schlindwein; Thomas van Bruggen; Marco Essig; Hans-Peter Meinzer
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-05-04       Impact factor: 2.924

Review 2.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

3.  Structural MRI volumetric analysis in patients with organic amnesia, 1: methods and comparative findings across diagnostic groups.

Authors:  A Colchester; D Kingsley; D Lasserson; B Kendall; F Bello; C Rush; T G Stevens; G Goodman; G Heilpern; N Stanhope; M D Kopelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

4.  The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.

Authors:  Adolfo Jiménez-Huete; Susana Estévez-Santé
Journal:  J Neurol Sci       Date:  2017-04-27       Impact factor: 3.181

5.  Do cognitive patterns of brain magnetic activity correlate with hippocampal atrophy in Alzheimer's disease?

Authors:  F Maestú; J Arrazola; A Fernández; P G Simos; C Amo; P Gil-Gregorio; S Fernandez; A Papanicolaou; T Ortiz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

6.  Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.

Authors:  Stefan J Teipel; Jens C Pruessner; Frank Faltraco; Christine Born; Manoela Rocha-Unold; Alan Evans; Hans-Jürgen Möller; Harald Hampel
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 7.  The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2014-02-01

8.  Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Sönke Arlt; Ralph Buchert; Lothar Spies; Martin Eichenlaub; Jan T Lehmbeck; Holger Jahn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-01       Impact factor: 5.270

9.  Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease.

Authors:  Daniel E Wollman; Isak Prohovnik
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

10.  Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Anna Zimny; Joanna Bladowska; Małgorzata Neska; Kamila Petryszyn; Maciej Guziński; Paweł Szewczyk; Jerzy Leszek; Marek Sąsiadek
Journal:  Med Sci Monit       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.